ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,339Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 1107

$1.42M Total Retail Price of All Prescriptions

Rank: 33 out of 1107

692 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 692 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

28% of this provider’s 692 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 19,268 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,484 1,048 S3 1 1
OMEPRAZOLE 980 725 2 4
FUROSEMIDE 777 659 3 7
LISINOPRIL 723 599 4 2
GABAPENTIN 600 381 5 9
POTASSIUM CHLORIDE 543 421 6 14
AMLODIPINE BESYLATE 541 449 7 6
LEVOTHYROXINE SODIUM 538 415 8 3
METOPROLOL TARTRATE 492 376 9 10
SIMVASTATIN 411 330 10 5
METOPROLOL SUCCINATE 407 376 11 16
METFORMIN HCL 364 256 12 8
ZOLPIDEM TARTRATE 334 266 13 22
HYDROCHLOROTHIAZIDE 316 276 14 11
MELOXICAM 312 180 15 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 307 178 16 24
WARFARIN SODIUM 287 244 17 15
NAMENDA 285 275 18 42
CITALOPRAM HBR 284 200 19 17
TRAMADOL HCL 272 165 20 26
RANITIDINE HCL 251 134 21 21
LOVASTATIN 240 195 22 55
NEXIUM 238 152 23 18
ENALAPRIL MALEATE 234 166 24 98
MIRTAZAPINE 223 193 25 61
DIGOXIN 218 205 26 52
TRIAMTERENE-HCTZ 211 183 27 62
ALLOPURINOL 205 186 28 36
CLOPIDOGREL 203 145 29 28
ISOSORBIDE MONONITRATE ER 203 180 29 34
METHOCARBAMOL 200 127 R 31 142
ATENOLOL 197 158 32 19
GLIMEPIRIDE 195 119 33 43
BUSPIRONE HCL 192 87 34 107
AMITRIPTYLINE HCL 178 90 R 35 48
ATORVASTATIN CALCIUM 173 96 36 13
EVISTA 173 173 36 135
TAMSULOSIN HCL 171 111 38 30
AZITHROMYCIN 168 126 39 35
SPIRONOLACTONE 167 124 40 72
PREDNISONE 164 106 41 40
PROMETHAZINE HCL 154 64 R 42 44
QUETIAPINE FUMARATE 152 86 43 94
SINGULAIR 148 88 44 65
CRESTOR 148 94 44 23
CARVEDILOL 145 132 46 27
PAROXETINE HCL 145 112 46 45
PRAVASTATIN SODIUM 144 117 48 12
TRAZODONE HCL 139 60 49 33
PLAVIX 136 100 50 39
SPIRIVA 135 59 51 57
RISPERIDONE 134 113 52 79
LANTUS 132 106 53 49
PANTOPRAZOLE SODIUM 131 78 54 30
SERTRALINE HCL 130 91 55 20
CEPHALEXIN 127 98 56 81
LEVETIRACETAM 127 76 56 141
DIOVAN 126 94 58 51
PROAIR HFA 125 39 59 37
CYMBALTA 119 75 60 50
FINASTERIDE 115 92 61 130
POLYETHYLENE GLYCOL 3350 107 79 62 46
DONEPEZIL HCL 107 88 62 32
FLUOXETINE HCL 105 45 64 47
ACTOS 104 57 65 132
LOSARTAN POTASSIUM 104 93 65 29
SULFAMETHOXAZOLE-TRIMETHOPRIM 104 70 65 88
JANUVIA 104 79 65 60
DOXAZOSIN MESYLATE 103 89 69 92
MECLIZINE HCL 97 72 70 114
PROPRANOLOL HCL 97 32 70 134
ZETIA 97 96 70 76
EXELON 95 89 73 103
METOCLOPRAMIDE HCL 91 36 74 116
NOVOLOG 91 69 74 127
TRICOR 90 71 76 95
CLONIDINE HCL 88 79 77 53
CIPROFLOXACIN HCL 87 68 78 59
FAMOTIDINE 87 74 78 111
METFORMIN HCL ER 84 54 80 58
BUMETANIDE 83 67 81 123
GEMFIBROZIL 83 43 81 107
INSULIN SYRINGE 82 71 83 78
ALENDRONATE SODIUM 81 69 84 41
PREMARIN 80 79 R 85 149
MONTELUKAST SODIUM 79 48 86 118
VENLAFAXINE HCL ER 78 42 87 117
SUCRALFATE 76 48 88 121
DILTIAZEM ER 76 57 88 139
DILTIAZEM 24HR CD 75 67 90 126
PIOGLITAZONE HCL 75 33 R 90 258
FLUTICASONE PROPIONATE 75 40 90 38
TRIAMCINOLONE ACETONIDE 74 61 93 137
BACLOFEN 73 40 94 133
DIOVAN HCT 72 55 95 106
LEVEMIR FLEXPEN 71 43 96 213
ROPINIROLE HCL 71 58 96 69
RANEXA 71 59 96 272
CYCLOBENZAPRINE HCL 70 43 R 99 56
SYMBICORT 68 46 100 124
CLOTRIMAZOLE-BETAMETHASONE 65 58 101 198
GLYBURIDE 64 15 R 102 68
LACTULOSE 64 44 102 89
PHENYTOIN SODIUM EXTENDED 64 24 102 147
ADVAIR DISKUS 63 24 105 54
KLOR-CON 10 62 62 106 143
JANUMET 61 27 107 197
SEROQUEL 60 37 108 182
OXYBUTYNIN CHLORIDE ER 58 58 109 179
OXYCODONE-ACETAMINOPHEN 57 43 S2 110 104
NORTRIPTYLINE HCL 56 56 111 267
ESCITALOPRAM OXALATE 56 44 111 82
LORATADINE 56 41 111 235
NITROFURANTOIN MONO-MACRO 55 54 114 207
CARISOPRODOL 55 24 R 114 146
CLINDAMYCIN HCL 55 39 114 334
KLOR-CON M20 54 31 117 75
AZELASTINE HCL 54 27 117 311
SOTALOL 53 39 119 222
TIZANIDINE HCL 53 16 119 73
COMBIVENT 52 24 121 112
IPRATROPIUM-ALBUTEROL 52 50 121 154
NITROSTAT 52 46 121 188
VYTORIN 52 40 121 169
FENTANYL 51 51 S2 125 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 2, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.